Prevalence of primary final result variations in clinical trials registered on ClinicalTrials.gov: a cross‐sectional study. F1000Res Palmitoylethanolamide (PEA) has been proposed to have practical analgesic Homes and also to be devoid of undesirable outcomes. Listed here, We now have examined critically this contention, and mentioned available data regarding the https://billn525qhx5.wikiadvocate.com/user